Evidence lead: Top-three record · High appeal-filing share
Independent Health MA: Appeals followed a large share of denials
454 appeals equal 15.0% of this contract's recorded denials. That is rank #1 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Top-three record · High appeal-filing share
Appeals followed a large share of denials
454 appeals equal 15.0% of this contract's recorded denials. That is rank #1 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Bottom-seven record · Smaller request-volume cohort
One of the narrower authorization records
The source records 48,000 requests here, placing the contract in the smallest-volume tier. Its request-volume rank is #31 of 37. Volume shows the denominator behind approvals and denials; it is not a measure of plan quality, membership, benefit breadth, price, or future coverage decisions.
Ranks twenty-one through twenty-five · Lower-middle denial cohort
Below the center of the denial-rate ordering
At 6.3%, this contract sits in the lower-middle part of the observed distribution. The exact rank is #24 of 37. This is aggregate prior-authorization activity for the reporting window, not a probability that a particular service, drug, or beneficiary request will be denied.
Ranks sixteen through twenty · Upper-middle overturn cohort
Appeal overturns ran above most contracts
The observed overturn rate is 71.0%, in the upper-middle portion of the table. Its overturn-rate rank is #17 of 37. The denominator is filed appeals, not all authorization requests. The percentage therefore describes reviewed appeals and must not be read as an individual outcome forecast.
Ranks sixteen through twenty · Upper-middle reversal reach
Reversals covered an above-median share of denials
Overturned appeals represent 10.6% of all denials here, based on 322 reversals. The cross-contract rank is #18 of 37. This derived measure combines appeal filing and outcome, so it supplies scale context but does not identify clinical reasons, administrative errors, or coverage rules.